Spanish is available via eTranslation, the European Commission's machine translation service.
Translate to Spanish | Important information about machine translation
EMA does not ask citizens for payment of any sort and does not send unsolicited communication.
We interact with companies and individuals on the basis of regulatory procedures we are responsible for.
For answers to frequently asked questions about EMA's work and scope, see:
Be vigilant for fake invoices, emails or phone calls impersonating EMA and requesting money transfers.
They can be scamming attempts.
They usually include EMA credentials like our name, emails, logo and even names of members of our staff.
EMA will never ask citizens for payment of any sort.
If you ever come across any such scamming attempt, consider reporting it to your national authorities competent for crimes and / or cybercrime.
Phishing is a form of online fraud in which senders pretend to be a trusted entity to obtain personal information, financial data or access codes.
EMA has identified phishing attempts where the sender pretends to work for EMA.
If you receive a suspicious email:
If necessary, follow up with EMA to confirm that the email is legitimate.
Remember that EMA never sends any unsolicited communication.
Stay informed about scams, phishing and other evolving social engineering practices.
EMA carries out scientific evaluation of new medicines meant for the EU market.
It also issues recommendations on whether or not new medicines can be marketed in the EU.
We also monitor the safety of all medicines already on the EU market.
Furthermore, we have a duty to respond to any query we receive.
EMA’s interactions with companies and individuals are often linked to these regulatory procedures.
To better understand what EMA does, see:
An update log is available to show the date and summary of changes to this webpage. It does not include updates to linked documents or minor edits like typos or broken link fixes.
The tracking of updates begins in June 2026.
18 June 2026